Search

Your search keyword '"Diego de Miguel-Pérez"' showing total 34 results

Search Constraints

Start Over You searched for: Author "Diego de Miguel-Pérez" Remove constraint Author: "Diego de Miguel-Pérez"
34 results on '"Diego de Miguel-Pérez"'

Search Results

1. KRAS and MET in non-small-cell lung cancer: two of the new kids on the ‘drivers’ block

2. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy

3. Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients

4. Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection.

5. Liquid biopsy from research to clinical practice: focus on non-small cell lung cancer

6. Immunotherapy in Lung Cancer: Are the Promises of Long-Term Benefit Finally Met?

8. Validation of a multiomic model of plasma extracellular vesicle PD-L1 and radiomics for prediction of response to immunotherapy in NSCLC

9. Platelets Lead Morphological, Phenotypic and Functional Changes in Tumor Cells

10. PCR-free and chemistry-based technology for miR-21 rapid detection directly from tumour cells

11. Immunotherapy in Lung Cancer: Are the Promises of Long-Term Benefit Finally Met?

12. Next Generation Sequencing for liquid biopsy based testing in Non-Small Cell Lung Cancer in 2021

13. Sandwich-Type Electrochemical Paper-Based Immunosensor for Claudin 7 and CD81 Dual Determination on Extracellular Vesicles from Breast Cancer Patients

14. Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer

15. Speeding tumor genotyping during the SARS‐CoV‐2 outbreak through liquid biopsy

16. Improving extracellular vesicles visualization: From static to motion

17. Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients

18. Post-Surgery Circulating Tumor Cells and AXL Overexpression as New Poor Prognostic Biomarkers in Resected Lung Adenocarcinoma

19. Post-Surgery Circulating Tumor Cells and

20. Exosomal miRNA profile as complementary tool in the diagnostic and prediction of treatment response in localized breast cancer under neoadjuvant chemotherapy

21. Liquid biopsy beyond of cancer: Circulating pulmonary cells as biomarkers of COPD aggressivity

23. Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents

24. P1.17 How to Visualize Exosomes in NSCLC: 'The New Guest Star in the Liquid Biopsy Movie'

25. Significance of EGFR Expression in Circulating Tumor Cells

26. Circulating Tumor Cells Identify Early Recurrence in Patients with Non-Small Cell Lung Cancer Undergoing Radical Resection

27. Extracellular vesicle PD-L1 dynamics predict durable response to immune-checkpoint inhibitors and survival in patients with non-small cell lung cancer

28. miRNA in situ hybridization in circulating tumor cells - MishCTC

29. Impact of Tyrosine Kinase Inhibitors on the Immune Response to SARS-CoV-2 Vaccination in Patients with Non-Small Cell Lung Cancer

30. Deep dissection of the antiviral immune profile of patients with COVID-19

31. Emerging noncoding RNAs contained in extracellular vesicles: rising stars as biomarkers in lung cancer liquid biopsy

32. O-021ASSOCIATION OF CIRCULATING TUMOUR CELLS WITH EARLY RELAPSE AND 18F-FDG PET UPTAKE IN RESECTED NON-SMALL CELL LUNG CANCER

33. Bispecific Antibodies in Cancer Immunotherapy: A Novel Response to an Old Question

34. Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents

Catalog

Books, media, physical & digital resources